Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 696

Dolomite

Intended Use: For use as a substitute for calcium and magnesium salts to enhance the mineral content of purified bottled water, with a maximum use level intended to provide 90.16 mg/L of calcium ions and 55 mg/L of magnesium ions.
Basis: Scientific procedures
Notifier: Hogan Lovells US LLP
Notifier Address: 555 Thirteenth Street, NW
Washington, DC 20004
GRAS Notice (releasable information): GRN 696 (in PDF) (900 kB)
Date of closure: Oct 3, 2017
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice (in PDF) (53 kB)
-
-